Device Trial Radar · NCT03791489
Multi-Treatment PNN Modulation for Chronic Rhinitis
Last checked: Nov 20, 2026Latest source record: Jul 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Dec 1, 2018
Primary completion
Jul 18, 2019
Study completion Jul 18, 2019
Sponsor
- Lead sponsor
- Arrinex, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 2, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Feasibility of treatment at multiple sites with the ClariFix cryoablation device for treatment of chronic rhinitis
Conditions
- Chronic Rhinitis
Interventions
ClariFixDevice
The ClariFix™ device (K162608) is an FDA 510(k) cleared Class II cryosurgical tool indicated for the destruction of unwanted tissue during surgical procedures, including in adults with chronic rhinitis.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Procedure-related Serious Adverse Events (SAEs) and/or Serious Adverse Device Effects (SADE)Time frame: Study duration (90-days)
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
San Francisco Otolaryngology Medical Group
San Francisco, California
Bethlehem ENT
Bethlehem, Pennsylvania
Tracy Byerly, MD
Fredericksburg, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.